雜志介紹

Pharmacogenomics雜志介紹

《Pharmacogenomics》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱藥物基因組學，本刊主要出版、報道醫(yī)學-PHARMACOLOGY & PHARMACY領域的研究動態(tài)以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術信息交流，提高行業(yè)發(fā)展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為1.9，最新CiteScore 指數為3.4。

本刊近期中國學者發(fā)表的論文主要有：

• SLCO1B3 T334G polymorphisms and mycophenolate mofetil-related adverse reactions in kidney transplant recipients

  Author: Zhong, Jianxun; Yang, Kun; Zhang, Mi; Wu, Jianhua; Liu, Liang

• Pharmacogenomics of oxcarbazepine in the treatment of epilepsy

  Author: Yuan, Yujie; Zhang, Shuang; Yuan, Yangyang; Yan, Xinjing; Zhang, Linlin; Ran, Yun Wei

• Application of next-generation sequencing in diffuse large B-cell lymphoma

  Author: Wang, Yudi; Jia, Suzhen; Cao, Xiubo; Ge, Shengchen; Yu, Kang; Chen, Yi

• A single-tube multiplex real-time PCR for HLA-B*38:02 genotype by detecting highly specific SNPs

  Author: Wang, Fei; Li, Wenqi; Wang, Xuan; Luo, Xiang; Dai, Penggao

英文介紹

Pharmacogenomics雜志英文介紹

Pharmacogenomics (ISSN 1462-2416) is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field.

Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field.